Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Yoko Goto"'
Autor:
Takahiro Iwai, Michio Yoshimura, Ryo Ashida, Yoko Goto, Takahiro Kishi, Satoshi Itasaka, Keiko Shibuya, Masashi Kanai, Toshihiko Masui, Akihisa Fukuda, Hiroyoshi Isoda, Masahiro Hiraoka, Takashi Mizowaki
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Background It is important to understand how elderly patients with locally advanced pancreatic carcinoma (LAPC) should be treated, since the number of elderly cancer patients will increase. However, the optimal treatment for elderly patients
Externí odkaz:
https://doaj.org/article/06356dba83074fbc837cc997ea381052
Autor:
Yoko Goto, Akira Nakamura, Ryo Ashida, Katsuyuki Sakanaka, Satoshi Itasaka, Keiko Shibuya, Shigemi Matsumoto, Masashi Kanai, Hiroyoshi Isoda, Toshihiko Masui, Yuzo Kodama, Kyoichi Takaori, Masahiro Hiraoka, Takashi Mizowaki
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background The purpose was to retrospectively evaluate the effect of intensity-modulated radiotherapy (IMRT) on gastrointestinal (GI) toxicities and outcomes compared to three-dimensional conformal radiotherapy (3DCRT) for locally advanced p
Externí odkaz:
https://doaj.org/article/7ad8f6a0cf284380836a37245903fa88
Autor:
Ryota Nakashima, Yoko Goto, Sho Koyasu, Minoru Kobayashi, Akiyo Morinibu, Michio Yoshimura, Masahiro Hiraoka, Ester M. Hammond, Hiroshi Harada
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Hypoxia-inducible factor 1 (HIF-1) has been recognized as an important mediator of the reprogramming of carbohydrate metabolic pathways from oxidative phosphorylation to accelerated glycolysis. Although this reprogramming has been associated
Externí odkaz:
https://doaj.org/article/0eb813fe8b2c4d88992eb98d2a5ae043
Publikováno v:
International Journal of Molecular Sciences, Vol 13, Iss 11, Pp 13949-13965 (2012)
Because of the accelerated proliferation of cancer cells and the limited distance that molecular oxygen can diffuse from functional tumor blood vessels, there appears to be a unique histology in malignant solid tumors, conglomerates of micro tumor co
Externí odkaz:
https://doaj.org/article/6f69862e86004630aca66aa8f1a48332
Autor:
Mayumi Hashimoto, Aiji Sato-Boku, Naoko Tachi, Yoko Okumura, Masahiro Okuda, Yoko Goto, HIdekazu Ito, Toshiyuki Kitoh
Publikováno v:
Cureus. 14(7)
Introduction A simple indicator of muscle damage is creatine kinase (CK). Although CK elevation is informative for malignant hyperthermia, no study has examined the relationship between the anesthetically awake state and CK in children. We aimed to p
Publikováno v:
Mammal Study. 47
Autor:
Nobuyuki Tsunoda, Hiromi Tokura, Atsuko Yamaguchi, Tomomi Sugino, Yoko Goto, Kazuhisa Aakahane, Miyuki Fujita
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 29:125-128
Publikováno v:
Cancer Science
Hypoxia‐inducible factor 1 (HIF‐1) is a critical heterodimeric transcription factor for tumor malignancy. Recently, ubiquitin carboxyl‐terminal hydrolase L1 (UCHL1) has been reported to function as a deubiquitinating enzyme for the stabilizatio
Autor:
Mitsuhiro Nakamura, Makoto Sasaki, Y. Ishihara, Yoko Goto, Takashi Mizowaki, Manabu Nakata, Naozo Sugimoto, Nobutaka Mukumoto
Publikováno v:
Journal of Applied Clinical Medical Physics
Purpose To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay ef
Autor:
Takashi Mizowaki, Keiko Shibuya, Toshihiko Masui, Yoko Goto, Ryo Ashida, Masashi Kanai, Akihisa Fukuda, Michio Yoshimura, Satoshi Itasaka, Takahiro Iwai, Masahiro Hiraoka, Takahiro Kishi, Hiroyoshi Isoda
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-10 (2020)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background It is important to understand how elderly patients with locally advanced pancreatic carcinoma (LAPC) should be treated, since the number of elderly cancer patients will increase. However, the optimal treatment for elderly patients with LAP